8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)
Published . Updated .
Key takeaways
- 8-K - First Tracks Biotherapeutics filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: TRAX
- Market reaction: TRAX +7.1% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - First Tracks Biotherapeutics filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- TRAX First Tracks Biotherapeutics+40.4% 30d
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TRAX | -1.35% | -2.76% | base | +5.85% | -2.15% | +3.25% | +7.13% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001193125-26-445405 Size: 423 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
First Tracks Biotherapeutics (TRAX)
First Tracks Biotherapeutics (TRAX) the next day, across 3 earlier stories: average +1.81%, largest gain +4.55%, largest drop +0.16%, from 3 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| First Tracks Biotherapeutics (TRAX) | the next day | +1.81% | +4.55% | +0.16% | 3 |
| First Tracks Biotherapeutics (TRAX) | three days later | +8.36% | +18.64% | +1.23% | 3 |
How far First Tracks Biotherapeutics (TRAX) has moved since 3 Nov 2026
Since the first closing price after “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer),” First Tracks Biotherapeutics (TRAX) is +1.13%.
| Company | When | Move | Status |
|---|---|---|---|
| First Tracks Biotherapeutics (TRAX) | that day | +5.85% | final price |
| First Tracks Biotherapeutics (TRAX) | the next day | -2.15% | final price |
| First Tracks Biotherapeutics (TRAX) | two days later | +3.25% | final price |
| First Tracks Biotherapeutics (TRAX) | three days later | +7.13% | final price |
| First Tracks Biotherapeutics (TRAX) | three days earlier | -2.76% | final price |
| First Tracks Biotherapeutics (TRAX) | five days earlier | -1.35% | final price |
Who gains and who loses around First Tracks Biotherapeutics (TRAX)
Companies mentioned with this story
- TRAX First Tracks Biotherapeutics
First Tracks Biotherapeutics (TRAX) is linked, with no stored direction, high confidence in the 3 Nov 2026 story “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> TRAX
First Tracks Biotherapeutics (TRAX)
The 3 Nov 2026 story “8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)” names First Tracks Biotherapeutics (TRAX) because of this story.
First Tracks Biotherapeutics (TRAX) is on the page because SEC 8-K filing -> direct issuer disclosure -> TRAX
Dates in the story, and the First Tracks Biotherapeutics (TRAX) price range
TRAX traded between 30.99 and 50.40 across 20 sessions. The latest close on file is 49.68.
A simple score for First Tracks Biotherapeutics (TRAX)
14 out of 100
“8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.